DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on June 1, 2009; DOI: 10.1124/dmd.109.028209


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.109.028209v1
37/9/1819    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by ZHU, H.-J.
Right arrow Articles by Markowitz, J. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZHU, H.-J.
Right arrow Articles by Markowitz, J. S.


Received for publication April 28, 2009.
Revised May 24, 2009.
Accepted for publication May 27, 2009.

Age and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver

Hao-Jie ZHU 1, David Appel 2, Yan Jiang 1, John S. Markowitz 3*

1 Medical University of South Carolina 2 MUSC 3 Medical University of South carolina

* Address correspondence to: E-mail: markowij{at}musc.edu

Abstract

Carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2) are two major hepatic hydrolases responsible for the metabolisms of numerous endogenous and exogenous compounds. In this study, age- and sex-dependent expression and activity of CES1 and CES2 were investigated utilizing both animal models and individual human liver s9 samples. The expression and activity of mouse CES1 (mCES1) and CES2 (mCES2) in the liver were markedly lower in newborns relative to adults, and increased gradually with age, approximating levels of adult animals by age 2 to 4-weeks. Similarly, the average human CES1 (hCES1) expression in the subjects < 1 year of age was significantly lower than that of pooled samples. In particular, hCES1 expression in the 13 day and 1 month-old subjects was just 20.3% and 11.1%, respectively, of the pooled sample values. Additionally, the subjects < 1 year of age exhibited a trend suggestive of low hCES2 expression, but this difference failed to reach statistical significance due to large interindividual variability. The expression and activity of mCES1 and mCES2 were not significantly altered after the animals were treated with human growth hormone, indicating growth hormone may not be associated with the low level of CES expression during early developmental stages. No significant differences of the expression and activity of mCES1 and mCES2 were observed between sexually mature male and female mice. In conclusion, the expression and activity of CES1 and CES2 are age-related, but independent of growth hormone level. Sex appears to be an unlikely factor contributing to the regulation of CES1 and CES2.


Key words: developmental pharmacology, developmental toxicology, liver microsomes, pharmacokinetics





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.